|
Home Company Vaccines Fetal & Stem Cell Research Abortion & Contraception Other Links Donate Search
|
Let The Pharmaceutical Companies Know How You Feel!The following companies plan to use the new aborted fetal cell line PER C6 to develop important new vaccines. They believe the public accepts such practices since there are existing vaccines using aborted fetal cell lines MRC-5 and WI-38 and the market is flourishing. Children of God for Life knows that if the majority of people in America knew what these companies were up to, it would swiftly bring an end to their sordid business. Stated Debi Vinnedge, Executive Director in a recent letter to these companies: "We know it is unnecessary to use this cell line and in doing so, your company image portrays a lack of concern for the sanctity and dignity of human life. It is really no different than the action of Nazis who performed experiments on the murdered Jews during the holocaust. A helpless segment of society was targeted and used as a commodity for the benefit of others then, just as the remains of these babies are being used today. And while we understand and support the need for new and effective treatments for infectious disease, such products should only be developed using the highest ethical standards."
Chiron Corporation - Purchased by Novartis Plans to use PER C6 in a new flu vaccine. Tell them not to! Use Novartis address below
Glaxo SmithKline (formerly SmithKline Beecham) Uses MRC-5 in their Hepatitis-A and Twinrix (Hepatitis-A-B combo) vaccines;
plans on using PER C6 in future Philadelphia, PA 19101
MedImmune, Inc. Plans on using PER C6 in a new Flu Vaccine
David M. Mott, CEO Merck & Company Uses WI-38 and MRC-5 in their MMR, Chickenpox, Hepatitis-A vaccines;
Plans on using PER C6 in new vaccines;
See special report and action needed! Merck & Company
Ken Frasier, CEO Whitehouse Station, NJ 08889-0100
Novartis
Broke off ties to
PER C6 and used moral cell
lines in their new flu vaccine. Dr Diane Rogers, Sr Director and VP Vaccine Development Novartis Vaccines and Diagnostics 45 Sidney Street Cambridge, MA 02139
Pfizer Corporation Plans to use embryonic stem cells in new drugs. Tell them not to! See Related Story - May 11, 2009
Jeffrey Kindler, CEO
Wayne Pisano, President & CEO
Schering-Plough - Recently bought by Merck
Plans on using PER C6 in future. Write to tell them not to!
Others National Institutes of Health (Governed by the Dept. of HHS)
Funding use of PER
C6 in flu, avian flu, swine flu, ebola vaccines.
CDC
Richard Besser, MD Acting
Director
FDA
Dr. Margaret A. Hamburg
We
have the right to protect the health and safety of our families without
violating our moral or religious beliefs!
Get
involved! Click here to learn more! |
Send mail to
info@cogforlife.org with
questions or comments about this web site.
|